Yuval Horn noted as one of 5 most highly regarded practitioners worldwide in life sciences transactions
March 16, 2015
Yuval Horn will co chair the keynote and corporate finance panels at the upcoming IBA World Life Sciences Conference on June 12 in Philadephia
March 12, 2015
Cellera, Inc. closes asset purchase agreement for undisclosed amount
March 12, 2015
Taboola.com closes $117 million private financing round
February 4, 2015
Adv. Roy Ribon and Adv. Ohad Mamann joined the firm as partners
January 13, 2015
Yuval Horn nominated Vice Chairman of the International Bar Association Technology Law Committee.
December 21, 2014
Medivation Inc. (represented by Horn & Co.) Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd.
November 23, 2014
Yuval Horn will join a panel at the upcoming IBA Annual Conference in Tokyo, Japan (October 2014).
October 21, 2014
Yuval Horn will moderate a panel at the upcoming IBA Annual Conference in Tokyo, Japan (October 2014).
October 21, 2014
Amnon Ovadia (Babylon Software Ltd.) purchases the translation business from Babylon Ltd. (TASE)
September 30, 2014
